Equity · Real Estate
SBRA
NASDAQSabra Health Care REIT (SBRA)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 5.3B USD
- P/E (TTM)
- 71.8
- Revenue, year to Dec 2025
- 356.9M USD
- EPS, diluted, year to Dec 2025
- 0.64 USD
- 52-week range
- 17.24 USD – 21.21 USD
- Avg volume
- 962.7K
as of Jul 17, 2026
Have Sabra Health Care REIT (SBRA) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, Sabra Health Care REIT insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 28 Nov 2025, show no open-market purchase.
Form 4, 90 days to 22 Nov 2026, newest reported trade 11 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 11 Nov 2026 | FOSTER MICHAEL JDirector | Sell | 10,000 | 210K USD |
| 08 Sep 2026 | MATROS RICHARD KChair, CEO and President | Sell | 200,000 | 4.2M USD |
| Sold | 2 open-market sales | 210,000 | $4.38M |
10 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 31 Aug 2026 | Barbarosh Craig A.Director | Award | 791 | |
| 31 Aug 2026 | Costa Michael LourencoExecutive VP, CFO & Treasurer | Award | 4,158 | |
| 31 Aug 2026 | Cusack CatherineDirector | Award | 791 | |
| 31 Aug 2026 | FLORES JESSICAExecutive VP & CAO | Award | 382 | |
| 31 Aug 2026 | FOSTER MICHAEL JDirector | Award | 791 | |
| 31 Aug 2026 | KATZMANN LYNNE SDirector | Award | 791 | |
| 31 Aug 2026 | Kono AnnDirector | Award | 791 | |
| 31 Aug 2026 | MATROS RICHARD KChair, CEO and President | Award | 13,867 | |
| 31 Aug 2026 | Malehorn Jeffrey A.Director | Award | 791 | |
| 31 Aug 2026 | Smith DarrinExecutive VP, CIO & Secretary | Award | 495 |
Which funds hold Sabra Health Care REIT (SBRA)?
9 of the 45 institutional funds we track reported a Sabra Health Care REIT position for the quarter ended 30 Sep 2026 — a combined 216.1M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 4,773,648 | 94.1M USD | +138.8% |
| Two Sigma Investments | Added | 3,874,199 | 76.4M USD | +98.9% |
| D. E. Shaw & Co. | Held (±25%) | 869,328 | 17.1M USD | +4.3% |
| Citadel Advisors | Added | 752,187 | 14.8M USD | +41.8% |
| Point72 Asset Management | Trimmed | 348,185 | 6.9M USD | −68.8% |
| Renaissance Technologies | New position | 137,979 | 2.7M USD | |
| Millennium Management | Trimmed | 80,271 | 1.6M USD | −89.2% |
| Balyasny Asset Management | Held (±25%) | 61,853 | 1.2M USD | +16.5% |
| Tudor Investment Corp | Trimmed | 59,651 | 1.2M USD | −90.6% |
| Man Group | Exited |
Have members of Congress traded Sabra Health Care REIT (SBRA)?
The most recent congressional trade disclosed in Sabra Health Care REIT is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 10 Apr 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 39 days |
| 01 Mar 2023 | Daniel S. Goldmanhouse · Democrat–NY | Purchase | 1K USD–15K USD | 47 days |
| 08 Nov 2022 | Sara Jacobshouse · Democrat–CA | Sale | 1K USD–15K USD | 34 days |
What has been filed or recorded for Sabra Health Care REIT (SBRA)?
The filings we hold for Sabra Health Care REIT, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Oct 2026 | Fails to deliver | Shares failed to deliver | 100 shares | 2K USD notional · <0.001% of shares out |
| 27 Oct 2026 | Fails to deliver | Shares failed to deliver | 39 shares | 771 USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 32,828 shares | 618K USD notional · 0.013% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.11 USD | Revenue $250M |
| 30 Sep 2026 | Financials | Total assets | 5.4B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 2.8B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.10 USD | Revenue $236M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.16 USD | Revenue $222M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.64 USD | Revenue $775M |
| 31 Dec 2025 | Financials | Revenue | 356.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 155.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.64 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.09 USD | Revenue $190M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.27 USD | Revenue $189M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.17 USD | Revenue $184M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.54 USD | Revenue $703M |
What do people ask about Sabra Health Care REIT (SBRA)?
What is Sabra Health Care REIT’s market cap?5.3B
Sabra Health Care REIT is worth 5.3B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Sabra Health Care REIT’s P/E ratio?71.8
Sabra Health Care REIT has a price-to-earnings ratio of 71.8, as of 17 Jul 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Sabra Health Care REIT’s revenue?356.9M
Sabra Health Care REIT reported revenue of 356.9M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Sabra Health Care REIT insiders bought or sold shares recently?2 sales
In the 90 days to 22 Nov 2026, Sabra Health Care REIT insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 28 Nov 2025, show no open-market purchase. A further 10 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Sabra Health Care REIT?9 of 45
9 of the 45 funds we track reported a Sabra Health Care REIT position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Two Sigma Investments and D. E. Shaw & Co. See Funds
Have members of Congress traded Sabra Health Care REIT?3 trades
Yes. 3 trades in Sabra Health Care REIT appear in the congressional disclosures we hold; the latest is a sale by Daniel S. Goldman (House, NY) dated 10 Apr 2023, filed 19 May 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Sabra Health Care REIT last report earnings?0.11
Sabra Health Care REIT last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.11 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Sara Jacobs: Kristie Baxter, Public domain; Daniel S. Goldman: US House, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words